Studying an immune-boosting injection with liver ablation for colorectal cancer that has spread to the liver
Part of Cancer, Digestive system clinical trials.
This trial combines a standard tumor-removal procedure (ablation) with an investigational drug injected into the liver to see if it helps your immune system fight the cancer. It is for people whose colorectal cancer has spread only to the liver and who are having all visible liver tumors treated with ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your colorectal cancer has spread only to the liver (up to 5 tumors, each 3 cm or smaller).
- You are going to have all liver tumors removed using a heat-based procedure (ablation), and you have no other cancer outside the liver.
- You have had no more than 2 lines of previous systemic therapy for metastatic colorectal cancer.
- You are in generally good health (able to care for yourself, but not necessarily able to work).
- Your liver, kidney, and blood functions are within acceptable ranges, and you are not on certain blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
This trial tests whether adding the drug IP-001 to tumor ablation (microwave or irreversible electroporation) helps control colorectal cancer that has spread to the liver. The goal is to find the best dose and see how the immune system responds.
This study tests an investigational drug called IP-001 given after surgery or microwave ablation for liver cancer. The goal is to help prevent the cancer from coming back.
This trial tests a combination treatment that uses heat or cold (ablation) to destroy liver tumors along with medicines that boost your immune system to fight cancer. It is for people whose colorectal cancer has spread to the liver and who could not have surgery, or whose first treatment stopped working.
This trial tests a combination of treatments for people with colorectal cancer that has spread to the liver and cannot be removed by surgery. It uses an oncolytic virus (which infects and kills cancer cells) along with radiation, chemotherapy, targeted therapy, and immunotherapy to try to shrink the liver tumors.
This trial tests a treatment to boost the immune system after a procedure called radiofrequency ablation (RFA) that uses heat to destroy liver tumors. It is for people with colorectal cancer that has spread to the liver but not elsewhere, and aims to see if this can improve outcomes.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.